What this Trial Is About

Researchers are assessing the safety and tolerability of taking Salvia haenkei, a dietary supplement, by mouth in healthy adults aged 55 to 65 years. Salvia haenkei is being studied for its potential anti-aging effects and its ability to improve muscle and organ functions such as kidney, liver, and heart health, as well as reduce inflammation and influence metabolism. Participants will receive one of two doses of Salvia haenkei dry extract in soft gel form: either 175 mg or 350 mg. The study is designed as an open-label, randomized trial with two parallel groups, each receiving a different dose to compare safety and tolerability. The treatment period lasts 90 days. During the study, participants will be closely monitored for any adverse events and their ability to tolerate the supplement without dropping out. Researchers will evaluate muscle and organ function, inflammation levels, and metabolic markers. The total duration for each participant is 90 days, during which adherence and health will be regularly assessed to ensure safety and gather information on the supplement's effects.

Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient